Big Pharma Gets 77,500% Return On Lobbying Investment


Big Pharma Gets 77,500% Return On Lobbying Investment

Repost From Stephen Cook

By Zaid Jilani, United Republic

April 4, 2012
It pays to hire an army of lobbyists

Investing is a time-honored American tradition. Millions of Americans
have some sort of investment, and the stock market is an honored
cultural institution.

But investing your money in a publicly traded company isn’t the only way to make a buck.

Let’s say you’re a powerful industry that wants to make a lot of
money with an enormous Return On Investment (ROI). One way you could do
so is by investing in lobbyists.

We here at United Republic have put together some stats about the
sort of ROI Big Money expects for its lobbying dollars in Washington.

As one example, an average American can expect a ROI of 11 percent
for investing in one Blue Chip stock in the Dow Jones Industrial Average
in 2010.

Meanwhile, Big Pharma has a ROI of 75,500 percent for the lobbying
dollars it spends to bar the government from bargaining for cheaper drug
prices through Medicare:

Of course, that money that Pharma and the rest of the industries on
the chart are making is at expense of American taxpayers and American
consumers.

But as long as we have a political system that bends to the whims of Big Money, the best ROI you can get is to be a lobbyist.

The sources used for this analysis include the Centre for Public Integrity and OpenSecrets.org.

Original Article Here: http://unitedrepublic.org/2012/big-pharma-gets-77500-return-on-lobbying-investment/
And Here: http://the2012scenario.com/2012/04/big-pharma-gets-77500-return-on-lobbying-investment/

 

Leave a Reply

Your email address will not be published. Required fields are marked *